1. Conget PA, Minguell JJ. Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J Cell Physiol. 1999; 181:67–73.
Article
2. Zhou S, Greenberger JS, Epperly MW, Goff JP, Adler C, Leboff MS, et al. Age-related intrinsic changes in human bone-marrowderived mesenchymal stem cells and their differentiation to osteoblasts. Aging Cell. 2008; 7:335–43.
Article
3. Ma D, Ma Z, Zhang X, Wang W, Yang Z, Zhang M, et al. Effect of age and extrinsic microenvironment on the proliferation and osteogenic differentiation of rat dental pulp stem cells in vitro. J Endod. 2009; 35:1546–53.
Article
4. Benetti R, Garcia-Cao M, Blasco MA. Telomere length regulates the epigenetic status of mammalian telomeres and subtelomeres. Nat Genet. 2007; 39:243–50.
Article
5. Gonzalo S, Jaco I, Fraga MF, Chen T, Li E, Esteller M, et al. DNA methyltransferases control telomere length and telomere recombination in mammalian cells. Nat Cell Biol. 2006; 8:416–24.
Article
6. Schroeder TM, Westendorf JJ. Histone deacetylase inhibitors promote osteoblast maturation. J Bone Miner Res. 2005; 20:2254–63.
Article
7. de Boer J, Licht R, Bongers M, van der Klundert T, Arends R, van Blitterswijk C. Inhibition of histone acetylation as a tool in bone tissue engineering. Tissue Eng. 2006; 12:2927–37.
8. Jeon EJ, Lee KY, Choi NS, Lee MH, Kim HN, Jin YH, et al. Bone morphogenetic protein-2 stimulates Runx2 acetylation. J Biol Chem. 2006; 281:16502–11.
Article
9. Atkinson SP, Keith WN. Epigenetic control of cellular senescence in disease: opportunities for therapeutic intervention. Expert Rev Mol Med. 2007; 9:1–26.
Article
10. Hu E, Tontonoz P, Spiegelman BM. Transdifferentiation of my-oblasts by the adipogenic transcription factors PPAR gamma and C/EBP alpha. Proc Natl Acad Sci U S A. 1995; 92:9856–60.
Article
11. Ogawa A, Ohba K, Uchida Y, Wada K, Yoshioka T, Muraki T. New adipogenic cell lines derived from C3H10T1/2. In Vitro Cell Dev Biol Anim. 1999; 35:307–10.
Article
12. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999; 284:143–7.
Article
13. Fang H, Yang X, Chen A, Luo Y. Effect of rhBMP-2 and osteogenic revulsants on proliferation and differentiation of bone marrow stromal cells in rats. J Huazhong Univ Sci Technolog Med Sci. 2007; 27:561–3.
Article
14. Osyczka AM, Diefenderfer DL, Bhargave G, Leboy PS. Different effects of BMP-2 on marrow stromal cells from human and rat bone. Cells Tissues Organs. 2004; 176:109–19.
Article
15. Justesen J, Stenderup K, Eriksen EF, Kassem M. Maintenance of osteoblastic and adipocytic differentiation potential with age and osteoporosis in human marrow stromal cell cultures. Calcif Tissue Int. 2002; 71:36–44.
Article
16. Kretlow JD, Jin YQ, Liu W, Zhang WJ, Hong TH, Zhou G, et al. Donor age and cell passage affects differentiation potential of murine bone marrowderived stem cells. BMC Cell Biol. 2008; 9:60.
Article
17. Mizuno D, Agata H, Furue H, Kimura A, Narita Y, Watanabe N, et al. Limited but heterogeneous osteogenic response of human bone marrow mesenchymal stem cells to bone morphogenetic protein-2 and serum. Growth Factors. 2010; 28:34–43.
Article
18. Diefenderfer DL, Osyczka AM, Reilly GC, Leboy PS. BMP responsiveness in human mesenchymal stem cells. Connect Tissue Res. 2003; 44(Suppl 1):305–11.
Article
19. Fleet JC, Cashman K, Cox K, Rosen V. The effects of aging on the bone inductive activity of recombinant human bone morphogenetic protein-2. Endocrinology. 1996; 137:4605–10.
Article